Article
Clinical phenotypes and disease outcomes of patients with systemic lupus erythematosus meeting indication for primary aldosteronism testing.
Lupus - 1 Oct 2026
Wong Matthew, Akram Muhammad, Kent Joanna R, Fuller Peter J, Hoi Alberta Y, Yang Jun, Vincent Fabien B
Abstract excerpt
BackgroundHypertension is prevalent and contributes significantly to cardiovascular risk in patients with systemic lupus erythematosus (SLE). Primary aldosteronism (PA), the most common endocrine cause of hypertension, confers higher cardiovascular risk than essential hypertension and has been linked to autoimmune diseases including SLE. While the prevalence of PA in SLE is unknown, a third of patients in a...
Read the complete abstract on PubMedTopics
- Humans
- Hyperaldosteronism
- Female
- Lupus Erythematosus, Systemic
- Retrospective Studies
- Phenotype
